Inovotion is a biotech company creating a unique in vivo technology exclusively designed for anti-cancer treatment evaluations and early toxicity studies. The company’s assay, characterized by being Fast, Sensitive, Reliable, and Affordable, is poised to save valuable time and resources, providing a distinct competitive advantage. This groundbreaking technology, centred on chick embryo methodology, facilitates early analysis of treatments before the traditional preclinical stages. The company has offices in Cambridge, MA.